Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets 
Most relevant news about IRONWOOD PHARMACEUTICALS,
02/23 IRONWOOD PHARMACEUTICALS : to Host R&D Day on March 9, 2017
02/21 IRONWOOD PHARMACEUTICALS : reports 4Q loss
02/21 IRONWOOD PHARMACEUTICALS : Provides Fourth Quarter and Full Year 2016 Investor U..
02/07 IRONWOOD PHARMACEUTICALS : to Host Fourth Quarter and Full-Year 2016 Investor Up..
01/30 IRONWOOD PHARMACEUTICALS : Astellas And Ironwood Report Positive Results From Ph..
01/30 IRONWOOD PHARMACEUTICALS : Astellas and Ironwood Report Positive Top-Line Result..
01/26 IRONWOOD PHARMACEUTICALS : U.S. Food and Drug Administration Approves 72 mcg Dos..
01/24 IRONWOOD PHARMACEUTICALS, INC. (NSDQ : IRWD) Has A Near Term Catalyst To Watch
01/09 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Results of Operations ..
01/09 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Termination of a Mater..
01/09 IRONWOOD PHARMACEUTICALS : Demonstrates Strong Execution on Strategy to Build To..
01/06 ACHAOGEN : Appoints Halley Gilbert to Its Board of Directors
01/04 IRONWOOD PHARMACEUTICALS : Appoints Amy Schulman to Board of Directors
01/04 IRONWOOD PHARMACEUTICALS : IRWD) Gains on NDA
01/04 IRONWOOD PHARMACEUTICALS : Announces New Drug Application for DUZALLO™ (Fi..
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
02/23 IRONWOOD PHARMACEUTICALS : to Host R&D Day on March 9, 2017
02/22 IRONWOOD PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
02/21 IRONWOOD PHARMACEUTICALS : reports 4Q loss
02/21 IRONWOOD PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fi..
02/21 IRONWOOD PHARMACEUTICALS : Provides Fourth Quarter and Full Year 2016 Investor U..
02/16 IRONWOOD PHARMACEUTICALS : to Host Fourth Quarter and Full-Year 2016 Investor Up..
02/09 ASTELLAS PHARMA : and Ironwood Report Positive Top-Line Results from Phase III L..
02/07 IRONWOOD PHARMACEUTICALS : to Host Fourth Quarter and Full-Year 2016 Investor Up..
02/02 IRONWOOD PHARMACEUTICALS : U.S. Food and Drug Administration Approves 72 mcg Dos..
02/01 IRONWOOD PHARMACEUTICALS INC : Entry into a Material Definitive Agreement (form ..
More news
Sector news : Biotechnology & Medical Research - NEC
02/22 Genmab and J&J's cancer drug set for blockbuster sales this year
02/21 Icahn buys Bristol-Myers shares, adding to activist pressure
02/21DJBristol-Myers Expands Board, Boosts Buybacks Amid Activist Pressure
02/16 How Sanofi lost out to J&J in $30 billion battle for Actelion
02/14 Gilead challenges GSK with strong HIV drug data
02/13 TEVA PHARMACEUTICAL INDUSTRIES : seeks CEO with pharma background to lead recove..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
02/24 SYNERGY : 3 Scenarios, 1 Choice
02/21 Ironwood Pharmaceuticals' (IRWD) CEO Peter Hecht on Q4 2016 Results - Earning..
02/21 Ironwood Pharmaceuticals, Inc. 2016 Q4 - Results - Earnings Call Slides
02/21 Ironwood Pharmaceuticals beats by $0.12, beats on revenue
02/20 Notable earnings after Tuesday?s close
02/09 SYNERGY PHARMACEUTICALS : Our Next Investment
Latest Tweets
02/24Synergy: 3 Scenarios, 1 Choice  
02/24Synergy: 3 Scenarios, 1 Choice  
02/24Ironwood Pharmaceuticals $IRWD – Investment Analysts’ Weekly Ratings Updates .. 
02/23Ironwood Pharmaceuticals : to Host R&D Day on March 9, 2017  
02/22Ironwood Pharmaceuticals's PT raised by Barclays PLC to $16.00. equal weight .. 
More tweets
Qtime:14
Advertisement
Financials ($)
Sales 2017 330 M
EBIT 2017 -55,0 M
Net income 2017 -84,2 M
Debt 2017 137 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 7,86x
EV / Sales 2018 6,02x
Capitalization 2 458 M
More Financials
Chart IRONWOOD PHARMACEUTICALS,
Duration : Period :
Ironwood Pharmaceuticals,  Technical Analysis Chart | IRWD | US46333X1081 | 4-Traders
Full-screen chart
Technical analysis trends IRONWOOD PHARMACE...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 16,7 $
Spread / Average Target -0,60%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Peter M. Hecht Chief Executive Officer & Director
Terrance G. McGuire Chairman
Thomas Graney Chief Financial Officer & SVP-Corporate Strategy
Mark G. Currie Chief Scientific Officer & Senior Vice President
Brian M. Cali Senior VP-Preclinical, Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
IRONWOOD PHARMACEUTICA..9.94%2 458
INCYTE CORPORATION21.03%23 098
QUINTILES IMS HOLDINGS..1.71%18 414
CELLTRION, INC.--.--%11 010
LONZA GROUP AG2.67%10 420
SEATTLE GENETICS, INC.22.38%8 928
More Results